Bimonthly Pegcetacoplan Is More Cost-Effective for Geographic Atrophy Than Monthly Treatment
A 2-year cost analysis suggests that long-term management of geographic atrophy with every-other-month pegcetacoplan may be more cost-effective than monthly treatment, though either option is expensiv